Research Award

Two Research Awards are offered by the Papanicolaou Society for Cytopathology to pathologists-in-training for abstracts presented at the Annual Meeting of the United States and Canadian Academy of Pathology.

The abstracts are evaluated for the novelty of the idea presented and the scientific and/or practical value of the topic. Winners are selected by members of the Research Committee.

The awards are presented at the Papanicolaou Society of Cytopathology Companion Meeting of the United States and Canadian Academy of Pathology.

To Qualify for the Award:

  1. Abstracts must be based on cytology material
  2. Abstracts must be accepted for platform or poster presentation at the 2006 Annual Meeting of the USCAP.
  3. The potential awardee must be a pathologist-in-training who played a major role in the development of the study and is listed as the first author of the paper.
  4. An application must be received by the PSC Research Award Committee by the deadline.

2021 Recipients

First Place
Simona De Michele MD, Resident
Columbia University Medical Center


Abstract ID: 118
Machine Learning/Convolutional Neural Network in Fluid Cytology for Predicting Malignancy

Authors: Simona De Michele, Columbia University Irving Medical Center, New York Presbyterian Hospital; Simon Sung, Albert Einstein College of Medicine, Montefiore Medical Center; Patricia Wasserman, Columbia University Medical Center
Second Place
Marina Baine, MD, Cytopathology Fellow
Memorial Sloan Kettering Cancer Center


Abstract ID: 635
Identification of Small Cell Lung Carcinoma Subtypes Defined by ASCL1, NEUROD1, YAP1 and POU2F3 in Cytology Specimens

Authors: Marina Baine, Memorial Sloan Kettering Cancer Center; Min-Shu Hsieh, National Taiwan University Hospital; Wei-Chu Lai, Memorial Sloan Kettering Cancer Center; Jacklynn Egger, Achim Jungbluth,; Xiao-Jun Wei,; Marc Rosenblum; Oscar Lin, Jennifer Sauter; Jason Chang; Darren Buonocore; William Travis; Triparna Sen; John Poirier, NYU Langone School of Medicine; Charles Rudin; Natasha Rekhtman, Memorial Sloan Kettering Cancer CenterĀ